Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Li

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Hematology/Oncology Clinics of North America|September 10, 2003
Surgical advances in the treatment of ovarian cancerAndrew J Li, Beth Y Karlan
Cancer Biology & Therapy|January 20, 2009
Androgens and epithelial ovarian cancer: What's the connection?Andrew J Li, Beth Y Karlan
Obstetrics and Gynecology|December 7, 2007
Peritoneal tuberculosis mimicking advanced-stage epithelial ovarian cancerR Geoffrey Elmore, Andrew J Li
Current Women'S Health Reports|July 13, 2002
Chemotherapy in epithelial ovarian cancerJing Wang, Andrew J Li, Beth Y Karlan
Gynecologic Oncology|October 13, 2009
Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancersAndrew J Li, Paula McAllister, Beth Y Karlan
Gynecologic Oncology|February 14, 2013
Obesity-associated adipokines correlate with survival in epithelial ovarian cancerElena S Diaz, Beth Y Karlan, Andrew J Li
Gynecologic Oncology|June 4, 2015
Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancerArthur-Quan Tran, Joshua G Cohen, Andrew J Li
American Journal of Obstetrics and Gynecology|July 16, 2003
Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell culturesAndrew J Li, Rae Lynn Baldwin, Beth Y Karlan
Obstetrics and Gynecology Clinics of North America|December 7, 2007
Hereditary ovarian cancer--assessing risk and prevention strategiesJames C Pavelka, Andrew J Li, Beth Y Karlan
Gynecologic Oncology|July 24, 2012
Impact of beta blockers on epithelial ovarian cancer survivalElena S Diaz, Beth Y Karlan, Andrew J Li
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Hematology/Oncology Clinics of North America|September 10, 2003
Surgical advances in the treatment of ovarian cancerAndrew J Li, Beth Y Karlan
Cancer Biology & Therapy|January 20, 2009
Androgens and epithelial ovarian cancer: What's the connection?Andrew J Li, Beth Y Karlan
Obstetrics and Gynecology|December 7, 2007
Peritoneal tuberculosis mimicking advanced-stage epithelial ovarian cancerR Geoffrey Elmore, Andrew J Li
Current Women'S Health Reports|July 13, 2002
Chemotherapy in epithelial ovarian cancerJing Wang, Andrew J Li, Beth Y Karlan
Gynecologic Oncology|October 13, 2009
Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancersAndrew J Li, Paula McAllister, Beth Y Karlan
Gynecologic Oncology|February 14, 2013
Obesity-associated adipokines correlate with survival in epithelial ovarian cancerElena S Diaz, Beth Y Karlan, Andrew J Li
Gynecologic Oncology|June 4, 2015
Impact of obesity on secondary cytoreductive surgery and overall survival in women with recurrent ovarian cancerArthur-Quan Tran, Joshua G Cohen, Andrew J Li
American Journal of Obstetrics and Gynecology|July 16, 2003
Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell culturesAndrew J Li, Rae Lynn Baldwin, Beth Y Karlan
Obstetrics and Gynecology Clinics of North America|December 7, 2007
Hereditary ovarian cancer--assessing risk and prevention strategiesJames C Pavelka, Andrew J Li, Beth Y Karlan
Gynecologic Oncology|July 24, 2012
Impact of beta blockers on epithelial ovarian cancer survivalElena S Diaz, Beth Y Karlan, Andrew J Li
Pageof 6